Skip to content
Home/Companies/Biotech/Core Biogenesis
Core Biogenesis

Core Biogenesis

Biotech·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Core Biogenesis?

Core Biogenesis is currently owned by XAnge through Digital 3 (2017 vintage), since 2020.

Hand-verified · updated 2026-04-21

XAnge
Investor
XAnge
Digital 3 · 2017 · VC

Key facts

HQFrance
SectorBiotech
Websitecorebiogenesis.com

More from Digital 3

Other portfolio companies in the same fund.

AssoConnect
AssoConnect
Exited 2025
SaaSFrance· 2020
to
Epigene Labs
Epigene Labs
Active
BiotechFrance· 2020
Omie & Cie
Active
ConsumerFrance· 2020
Apiax
Apiax
Active
LegalTechSwitzerland· 2019
Implicity
Implicity
Active
HealthTechFrance· 2019
Sweagle
Exited 2020
DevToolsBenelux· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Core Biogenesis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Core Biogenesis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue